L
Laurence Collette
Researcher at European Organisation for Research and Treatment of Cancer
Publications - 281
Citations - 37642
Laurence Collette is an academic researcher from European Organisation for Research and Treatment of Cancer. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 78, co-authored 276 publications receiving 33811 citations. Previous affiliations of Laurence Collette include VU University Amsterdam & Université catholique de Louvain.
Papers
More filters
Journal ArticleDOI
Uptake of two 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001).
Andrea Wittig,Massimo Malagó,Laurence Collette,René Huiskamp,Sandra Bührmann,V. A. Nievaart,Gernot M. Kaiser,Karl-Heinz Jöckel,Kurt Werner Schmid,Uta Ortmann,Wolfgang Sauerwein +10 more
TL;DR: In conclusion, BSH is not suitable as 10B‐carrier in liver metastases as the10B‐concentration in liver was higher compared to metastasis, and BPA accumulates in hepatic metastases to an extent that allows for extracorporeal irradiation of the liver with BNCT.
Journal ArticleDOI
Preoperative radiation (Preop RT) in rectal cancer: Effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial
J.F. Bosset,Gilles Calais,Laurent Mineur,Philippe Maingon,L. Radosevic-Jelic,Alain Daban,Etienne Bardet,Alexander Beny,Jean-Claude Ollier,Laurence Collette +9 more
TL;DR: A 2 x 2 factorial trial evaluates the addition of CT to preop RT and that of postop CT vs nil on overall survival and progression-free survival in patients with atypical central giant cell granuloma.
Journal ArticleDOI
Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892.
Fritz H. Schröder,Peter Whelan,Theo M. de Reijke,K. H. Kurth,Michele Pavone-Macaluso,J Mattelaer,Roland Van Velthoven,Muriel Debois,Laurence Collette +8 more
TL;DR: In this paper, the authors compared the efficacy of Flutamide (FLU) versus Cyproterone acetate (CPA) in men with metastatic prostate cancer and favorable prognostic factors.
Journal ArticleDOI
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).
Oscar Matzinger,Oscar Matzinger,F. Roelofsen,Laurent Mineur,S. Koswig,E. Van der Steen-Banasik,P. Van Houtte,Karin Haustermans,L. Radosevic-Jelic,R.P. Mueller,P. Maingon,Laurence Collette,J.F. Bosset +12 more
TL;DR: Radio-chemotherapy with MMC/CDDP seems promising as only MMC orCDDP demonstrated enough activity (RECIST ORR >75%) to be tested further in phase III trials; MMC /5-FU did not.
Journal ArticleDOI
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Patrick Schöffski,Agnieszka Wozniak,Silvia Stacchiotti,Piotr Rutkowski,J.-Y. Blay,Lars H. Lindner,Sandra J. Strauss,Alan Anthoney,Florence Duffaud,Susan Richter,Viktor Grünwald,M. G. Leahy,Peter Reichardt,Jozef Sufliarsky,W.T.A. van der Graaf,W.T.A. van der Graaf,Raf Sciot,Maria Debiec-Rychter,T. van Cann,Sandrine Marreaud,Michela Lia,Tiana Raveloarivahy,Laurence Collette,Sebastian Bauer +23 more
TL;DR: The PFS with crizotinib in MET+ CCSA is similar to results achieved first-line in non-selected metastatic soft tissue sarcomas with single-agent doxorubicin, and results achieved with pazopanib in previously treated sarcoma patients.